JORDAN SMITH: Open Payments
NPI 1013514553 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,027 in 187 payments from 16 companies in 2025. Trend: 2023 $2,790 · 2024 $2,646 · 2025 $3,027
Food & beverage: $3,027
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $655 |
| Janssen Biotech, Inc. | 18 | $317 |
| Novartis Pharmaceuticals Corporation | 37 | $314 |
| UCB, Inc. | 16 | $270 |
| Amgen Inc. | 16 | $232 |
| E.R. Squibb & Sons, L.L.C. | 10 | $228 |
| Mallinckrodt Hospital Products Inc. | 7 | $197 |
| AstraZeneca Pharmaceuticals LP | 10 | $181 |
| PFIZER INC. | 8 | $174 |
| GlaxoSmithKline, LLC. | 5 | $121 |
Products named: SKYRIZI, COSENTYX, TREMFYA, RINVOQ, Bimzelx, ORENCIA, ACTHAR, XELJANZ.
Industry payments across MS — which companies pay providers there.
